This company is no longer active
Deversify Health (9BX) Stock Overview
Develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
9BX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ZenaTech: A big bet on the rise of AI drones and drones-as-a-service
Key Takeaways ZenaTech is focusing its efforts into building AI drones, combining Drone as a Service, SaaS, and AI as its key revenue drivers. Previously building software for agriculture, ZenaTech has shifted rapidly toward drone services, now driving ~70% of revenue after recent acquisitions.Read more
Deversify Health AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0004 |
| 52 Week High | SEK 0.015 |
| 52 Week Low | SEK 0.0002 |
| Beta | 0 |
| 1 Month Change | -60.00% |
| 3 Month Change | 0% |
| 1 Year Change | -96.97% |
| 3 Year Change | -99.95% |
| 5 Year Change | n/a |
| Change since IPO | -99.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9BX | DE Software | DE Market | |
|---|---|---|---|
| 7D | -33.3% | 4.3% | 3.4% |
| 1Y | -97.0% | -35.5% | 8.1% |
Return vs Industry: 9BX underperformed the German Software industry which returned 63.5% over the past year.
Return vs Market: 9BX underperformed the German Market which returned 13.6% over the past year.
Price Volatility
| 9BX volatility | |
|---|---|
| 9BX Average Weekly Movement | 135.7% |
| Software Industry Average Movement | 6.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in DE Market | 13.8% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 9BX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 9BX's weekly volatility has increased from 81% to 136% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Lotta Thornqvist | deversify.com |
Deversify Health AB (publ) develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers. The company offers Acetrack, a ketone breathalyzer to determine whether a person is found to be in ketosis or not; and Elitista, a health education platform that provides customers with knowledge and tools to learn about their own metabolic health. The company is headquartered in Uppsala, Sweden.
Deversify Health AB (publ) Fundamentals Summary
| 9BX fundamental statistics | |
|---|---|
| Market cap | €21.97k |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
Is 9BX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9BX income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 9BX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/04 14:27 |
| End of Day Share Price | 2024/11/04 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Deversify Health AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.